DiNardo Discusses VIALE-A and Venetoclax Combo in AML

Season 3 Episode 25  ·  Jul 30, 2020, 07:00 PM

Headliner
Share
Subscribe

In our exclusive interview, Dr. DiNardo discussed the role of venetoclax in AML and explained the significance of the results of the VIALE-A trial.

Share
Subscribe
Next
FDA Approval Insights: Brexucabtagene Autoleucel in Relapsed/Refractory MCL
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air